Addy, Carol
Universidade Federal do Rio Grande · Universidade Federal do Rio Grande do Sul · University of Miami · Ege University · Hospital de Clínicas de Porto Alegre · Azienda Ospedaliero-Universitaria di Modena · Genfit (France) · Liver Institute Northwest · University of California Davis Medical Center · University of Milano-Bicocca · University of California, Davis
3 papers on CoChatORCID 0000-0003-1028-2649
Most cited papers
- Verified
Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation
Kim, C.-W., Addy, C., Kusunoki, J., Anderson, N. N., Deja, S., Fu, X., Burgess, S. C., Li, C., Ruddy, M., Chakravarthy, M., et al. (2017) · Cell Metabolism
Liver Disease Diagnosis and TreatmentCancer, Lipids, and Metabolism
Cited by 419
- Verified
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
Kowdley, K. V., Bowlus, C. L., Levy, C., Akarca, U. S., Alvares-da-Silva, M. R., Andreone, P., Arrese, M., Corpechot, C., Francque, S. M., Heneghan, M. A., et al. (2024) · New England Journal of Medicine
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 314
- Verified
Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess.
Chan, J. L., Bullen, J., Stoyneva, V., DePaoli, A. M., Addy, C., & Mantzoros, C. S. (2005) · The Journal of Clinical Endocrinology & Metabolism
Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity
Cited by 60
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free